In the field of blood components and plasma-derived medicinal products, scientific developments and changes in insights and policy occur frequently and continuously. The early 1990’s witnessed significant developments in the field of plasma derivatives. Many new regulations were developed, science and technology progressed, influence of patients increased, and quality and safety became top priority issues. IPFA responded by organising more than 40 international meetings to address all these key issues. The main aim was to provide platforms for information sharing among all IPFA member organisations, IPFA experts, and the wider industry and also to further develop relationships with the international regulatory community. These international events also created opportunities for establishing partnerships and for networking. Recognised international experts from IPFA members and other stakeholders have consistently and generously contributed to these events.
The first workshop on screening and testing using Nucleic Acid Amplification Technology (PCR/NAT) was organized in 1994, as a result of the rapid emergence of this technology and its potential to increase the safety of blood and plasma products.
At the meetings that followed, donor epidemiology, collection of blood and plasma, manufacture of plasma derivatives and the prevention of transmission of blood borne pathogens including TSE/vCJD has been addressed. IPFA has a strong tradition of promoting international scientific and policy debate on these key issues and will continue to do so with the aim of promoting science-based decision making.
PFA/BCA Global Symposium on the Future for Blood and Plasma Donations, USA.
IPFA/PEI International Workshop on Surveillance and Screening of Blood Borne Pathogens